Beta thalassemia major, also known as Cooley’s anemia and transfusion-dependent beta thalassemia, causes the body’s red blood cells to produce less hemoglobin than usual.
Read More
The hospital said the second breach notice is related to additional concerns about Anthem’s claim-payment practices and its failure to apply a contract between the hospital and the insurance company correctly.
Read More
The Indianapolis-based drugmaker will work to support UNICEF’s efforts to strengthen primary health care systems to prevent, detect and manage noncommunicable diseases in children and adolescents.
The Indianapolis-based drugmaker is marking 150 years since Col. Eli Lilly founded his company on May 10, 1876.
Former Indianapolis Colts quarterback Peyton Manning emceed the event, which took place before about 500 attendees at the new Lilly Event Center in downtown Indianapolis.
Lilly’s latest commitment at the LEAP District brings the company’s total investment there since 2022 to $18 billion.
In October, Corteva’s board of directors unanimously approved a plan to separate the company’s crop protection business and its seed business into two independent companies.
In February, Beck’s publicly launched SeedIQ, a free online product management platform that uses artificial intelligence to provide data and management recommendations to help farmers unlock the potential of their corn and soybean hybrids.
In Indiana, gone are Eleven Fifty Academy and Kenzie Academy. National coding bootcamps like Bloom Institute of Technology, Hack Reactor and Triology have significantly scaled back or totally restructured in recent years.
The Indianapolis-based drugmaker reported profit of $7.4 billion for the first quarter, up from $2.8 billion in the same period a year earlier.
The Indianapolis-based drugmaker will partner with Profluent to develop and commercialize treatments for diseases with severe unmet needs.
The acquisition is the latest in a series of recent deals that Indianapolis-based Eli Lilly and Co. has made to increase its cancer-treatment pipeline.
The laborious process of naming a pharmaceutical takes months and sometimes years of brainstorming, trademark review, legal analysis and regulatory compliance.
The region stands out for its prowess in invention and innovation, but competing markets have mastered telling their stories, according to speakers at IBJ’s Life Sciences Power Breakfast.
Dr. Mark Payne, a professor of pediatrics at the Indiana University School of Medicine and a pediatric cardiologist at Riley Children’s Health, has been working on a treatment for a neurodegenerative condition called Friedreich’s ataxia for decades.
The focus of the agreement is to meet the evolving needs of Indiana’s orthopedic sector, which represents one-third of the industry’s global workforce.
Derek B. Groves will join Community Health Network Foundation in May as part of a planned leadership transition. He will succeed longtime CEO Joyce Irwin.
The company has a goal to build a massive bank of bone marrow from deceased organ donors to treat patients with blood cancers and improve organ transplantations.
Hospital CEO Brenda Reetz the insurance underpayment situation impacts patient bills, hospital stability and access to care. Indianapolis-based Anthem said it is working with the hospital to resolve the problem.
Through the collaboration, Telix and Regeneron expect to develop and commercialize next-generation radiopharmaceutical therapies targeting cancer.
Luke Kissam will lead New Corteva after Corteva officially separates its pesticide and seed businesses into two independent, publicly traded companies.
Nunery explains how she led her company — Illumend powered by myCOI — from an RV while traveling the country during the pandemic.
